XLRN - Acceleron Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $7.27. This is a potential upside of $7.27 (0%) from yesterday's end of day stock price of $0.

Acceleron Pharma's activity chart (see below) currently has 157 price targets and 89 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.21% with an average time for these price targets to be met of 171.11 days.

Most recent stock forecast was given by DANIELLE BRILL from RAYMOND JAMES on 08-Oct-2021. First documented stock forecast 14-Aug-2014.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 years 6 months 18 days ago

15/16 (93.75%)

$7.9 (4.59%)

248

Hold

180

$1.25 (0.70%)

180

2 years 6 months 18 days ago

0/4 (0%)

$34.21 (26.40%)

Hold

180

$1.25 (0.70%)

168

2 years 6 months 25 days ago

14/15 (93.33%)

$5.65 (3.24%)

303

Hold

180

$1.25 (0.70%)

122

2 years 6 months 25 days ago

4/5 (80%)

$5.65 (3.24%)

133

Hold

180

$1.25 (0.70%)

146

2 years 6 months 25 days ago

7/8 (87.5%)

$5.65 (3.24%)

119

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is XLRN (Acceleron Pharma) average time for price targets to be met?

On average it took 171.11 days on average for the stock forecasts to be realized with a an average price target met ratio 84.21

Which analyst has the current highest performing score on XLRN (Acceleron Pharma) with a proven track record?

YARON WERBER

Which analyst has the most public recommendations on XLRN (Acceleron Pharma)?

Yaron Werber works at TD COWEN and has 11 price targets and 4 ratings on XLRN

Which analyst is the currently most bullish on XLRN (Acceleron Pharma)?

Jeffrey Hung with highest potential upside - $1.25

Which analyst is the currently most reserved on XLRN (Acceleron Pharma)?

Geoff Meacham with lowest potential downside - -$133.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?